Skip to main content
Premium Trial:

Request an Annual Quote

Genset Names Abarbanel CIO and CTO

NEW YORK, July 2 – Genset has named Robert Abarbanel chief information officer and chief technical officer, the company announced Monday.

Abarbanel previously worked at Boeing, where he served as a manager and principal scientist in mathematics and computing technology. Prior to that he served in the advanced technology group at Apple Computer and IntelliGenetics (acquired by Oxford Molecular Group), and was a principal investigator researching computing techniques applied to protein folding and search algorithms at the University of California. He started his career as a pediatrician at San Luke’s Hospital in San Francisco.

“The integration of biology and IT will be required to discover and develop novel genomics-based biopharmaceutical products,” Andre Pernet, CEO of Genset, said in a statement. “I truly believe that Dr. Abarbanel has the unique background as a trained physician with over 20 years in cutting edge statistical and technological advances to take us to the next level in this area.”

Abarbanel will be based at Genset’s Paris headquarters.

The Scan

Booster for At-Risk

The New York Times reports that the US Food and Drug Administration has authorized a third dose of the Pfizer-BioNTech SARS-CoV-2 vaccine for people over 65 or at increased risk.

Preprints OK to Mention Again

Nature News reports the Australian Research Council has changed its new policy and now allows preprints to be cited in grant applications.

Hundreds of Millions More to Share

The US plans to purchase and donate 500 million additional SARS-CoV-2 vaccine doses, according to the Washington Post.

Nature Papers Examine Molecular Program Differences Influencing Neural Cells, Population History of Polynesia

In Nature this week: changes in molecular program during embryonic development leads to different neural cell types, and more.